Takeaways: Devonian’s Thykamine study could expand its antioxidant and anti-inflammatory platform into supportive oncology, targeting radiation-induced skin injury in breast cancer patients. Com...
Takeaways: The expanded approval of Lynkuet for AET‑related VMS gives Canadian oncologists and breast cancer patients the first non‑hormonal, evidence‑based option specifically indicated for...
